Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Tubulis rides wave of ADC interest to $138M financing round
The antibody-drug conjugate craze shows no signs of slowing down any time soon, judging by Tubulis’ latest financing.
James Waldron
Mar 14, 2024 9:12am
Fierce Biotech Fundraising Tracker: Tubulis, Alumis & more
Mar 14, 2024 8:51am
Alumis raises $259M in 2024's largest biotech round so far
Mar 6, 2024 8:00am
Sionna adds $182M to extend pipeline, cash runway through 2026
Mar 6, 2024 8:00am
VC investment in biopharma dropped nearly $7B in 2023: PitchBook
Mar 5, 2024 5:00am
A new biotech blooms with $100M to take on small molecules
Feb 29, 2024 9:30am